Roughly three-quarters of pharmacists said they would feel confident or very confident substituting an interchangeable biosimilar for its branded biologic counterpart if the two products share the same nonproprietary name.
The Academy of Managed Care Pharmacy applauds the House Ways & Means Committee for approving legislation that contains measures to prevent prescription drug abuse under the Medicare Part D program.
GPhA applauds the bipartisan reintroduction of the Food and Drug Administration Safety Over Sequestration Act.
Urging recognition of pharmacists as health care providers under Medicare Part B, NACDS cited that retail pharmacies are often the most readily accessible health care provider.
The National Community Pharmacists Association has written lawmakers to provide pharmacists’ feedback and recommendations to improve so-called "lock-in pharmacy” provisions within H.R. 1021.
The American Society for Consultant Pharmacists has announced it will host a discussion for all stakeholders in long-term care.
The National Association of Chain Drug Stores expressed support for the Military Compensation and Retirement Modernization Commission's recognition of preserving pharmacy access and choice for TRICARE patients.
Biosimilars are poised to dramatically impact patient care in the United States.